1,900
Views
9
CrossRef citations to date
0
Altmetric
Articles

Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study

, , , , , , , , & ORCID Icon show all
Pages 1023-1030 | Received 09 Feb 2021, Accepted 15 Jun 2021, Published online: 05 Jul 2021

References

  • Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158.
  • Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–178.
  • Gasser RW. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr. 2013;163(17–18):397–402.
  • Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93(9):3462–3470.
  • Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561–3569.
  • Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959–968.
  • Hamdy NA. Parathyroid gland: is parathyroidectomy safe and beneficial in the elderly? Nat Rev Endocrinol. 2009;5(8):422–423.
  • Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
  • Korkusuz H, Wolf T, Grunwald F. Feasibility of bipolar radiofrequency ablation in patients with parathyroid adenoma: a first evaluation. Int J Hyperthermia. 2018;34(5):639–643.
  • Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol. 2019;29(10):5607–5616.
  • Liu F, Yu X, Liu Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperthermia. 2019;36(1):835–840.
  • Wei Y, Peng L, Li Y, et al. Clinical study on safety and efficacy of microwave ablation for primary hyperparathyroidism. Korean J Radiol. 2020;21(5):572–581.
  • Ye J, Huang W, Huang G, et al. Efficacy and safety of US-guided thermal ablation for primary hyperparathyroidism: a systematic review and meta-analysis. Int J Hyperthermia. 2020;37(1):245–253.
  • Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21(12):1383.
  • Appelbaum L, Goldberg SN, Ierace T, et al. US-guided laser treatment of parathyroid adenomas. Int J Hyperthermia. 2020;37(1):366–372.
  • Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology. 2014;273(1):241–260.
  • Xu SY, Wang Y, Xie Q, et al. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med J. 2013;54(7):e137–e140.
  • Sormaz IC, Poyanli A, Acar S, et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol. 2017;40(4):596–602.
  • Wu W, Zhou Q, Xu S, et al. Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism. Endocrine. 2021;71(2):476–483.
  • Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253(3):585–591.
  • Singh ON, Rodriguez-Gutierrez R, Maraka S, et al. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. 2016;40(10):2359–2377.
  • Alhefdhi A, Schneider DF, Sippel R, et al. Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas. J Surg Res. 2014;190(1):198–202.
  • National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.
  • Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98–109.
  • Bucy D, Pollard R, Nelson R. Analysis of factors affecting outcome of ultrasound-guided radiofrequency heat ablation for treatment of primary hyperparathyroidism in dogs. Vet Radiol Ultrasound. 2017;58(1):83–89.
  • Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep. 2017;7(1):9554.
  • Ahmed M, Brace CL, Lee FJ, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
  • Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650.